HC Wainwright & Co. Maintains Buy on Kodiak Sciences, Raises Price Target to $96

9/28/2026
Impact: 75
Healthcare

HC Wainwright & Co. analyst Matthew Caufield has maintained a 'Buy' rating on Kodiak Sciences (NASDAQ: KOD) and increased the price target from $58 to $96.

AI summary, not financial advice

Share: